Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication

Bicyclol is a synthetic drug for hepatoprotection in clinic since 2004. Preliminary clinical observations suggest that bicyclol might be active against hepatitis C virus (HCV) with unknown mechanism. Here, we showed that bicyclol significantly inhibited HCV replication in vitro and in hepatitis C pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Meng-Hao, Li, Hu, Xue, Rong, Li, Jianrui, Wang, Lihua, Cheng, Junjun, Wu, Zhouyi, Li, Wenjing, Chen, Jinhua, Lv, Xiaoqin, Li, Qiang, Lan, Pei, Zhao, Limin, Yang, Yongfeng, Peng, Zonggen, Jiang, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663943/
https://www.ncbi.nlm.nih.gov/pubmed/31384537
http://dx.doi.org/10.1016/j.apsb.2019.01.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663943/
https://www.ncbi.nlm.nih.gov/pubmed/31384537
http://dx.doi.org/10.1016/j.apsb.2019.01.013

Ejemplares similares